Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRMT6 is the non-catalytic subunit of the tRNA (adenine^58^-N1)-methyltransferase complex, which forms a heterodimer with the catalytic subunit TRMT61A[3]. This complex catalyzes the methylation of adenine 58 in the T-loop of tRNA (m^1^A^58^)—a conserved modification essential for proper tRNA folding and function. TRMT6 lacks a functional methyltransferase active site but is necessary for tRNA binding and substrate specificity, facilitating the positioning of substrate tRNA for modification by TRMT61A. Disruption of TRMT6 impairs m^1^A^58^ formation and tRNA stability, impacting translation efficiency and fidelity. Deficiencies or misregulation in the complex have been linked to defects in protein biosynthesis and, in model organisms, to abnormal cellular growth and disease phenotypes[3]. Summary: - The phrase "tRNA methyltransferase 6 non-catalytic subunit" most accurately refers to TRMT6, the non-catalytic part of a methyltransferase complex (TRMT6/TRMT61A) in humans responsible for a specific tRNA adenine methylation. It is not a receptor, but a critical component required for enzymatic tRNA modification activity[3]. - The molecule is essential for cell biology but not currently targeted by drugs. - The term is somewhat imprecise—human naming conventions prefer “TRMT6” (or for the complex, “tRNA (adenine(58)-N1)-methyltransferase complex”)[3].
Not applicable for direct drug action, but genetic knockdown or mutation ablates tRNA m^1A^58 methylation, disrupting normal RNA processing[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA methyltransferase 6 non-catalytic subunit (TRMT6).